Table 3 summarizes the molecular responses to pharmacological Nrf2 activation reported in human CKD. For comparison, Table 4 summarizes examples of molecular responses to pharmacological Nrf2 activation in non-CKD patients/models or cells. The gene discussed is NFE2L2; the disease is chronic kidney disease.